Welcome to Health Care POV | sign in | join
ADVANCE Perspectives: Healthcare Information Professionals

Tapping Crowd-Sourced Data Unearths a Trove of Depression Genes

Published August 5, 2016 7:00 AM by ADVANCE Perspectives

By ADVANCE Perspectives

 

Here’s a look at some interesting research on gene typing released by the National Institutes of Health this week.

 

(NIH) — Scientists have discovered 15 genome sites — the first ever — linked to depression in people of European ancestry. Many of these regions of depression-linked genetic variation turn out to be involved in regulating gene expression and the birth of new neurons in the developing brain.

SEE ALSO: DNA May Determine Who Gets Sick

But – in a twist – the researchers didn’t have to sequence anyone’s genes. Instead, they analyzed data already shared by people who had purchased their own genetic profiles via an online service and elected to participate in its research option. This made it possible to leverage the statistical power of a huge sample size to detect weak genetic signals associated with a diagnosis likely traceable to multiple underlying illness processes.

 

This novel use of crowd-sourced data was confirmed with results from traditional genetics approaches in the study, funded by the National Institutes of Health.

 

Roy Perlis, MD, MSC, of Harvard/Massachusetts General Hospital — a grantee of the NIH’s National Institute of Mental Health (NIMH) and National Human Genome Research Institute (NHGRI) — and colleagues from industry, report on their findings August 1, 2016 in the journal Nature Genetics.

 

It’s well known that at least some depression runs in families and some risk is inherited. Yet, prior to this study, conventional genome-wide approaches had failed to reliably identify chromosomal sites associated with the illness in populations with European roots. Since depression is thought to be like fever — a common set of symptoms likely rooted in multiple causes — lumping together genetic data from people with different underlying illness processes likely washed out, or statistically diluted, subtle evidence of effects caused by risk genes.

 

To increase their odds of detecting these weak genetic signals, the researchers adopted a strategy of studying much larger samples than had been used in the earlier genome-wide studies. They first analyzed common genetic variation in 75,607 people of European ancestry who self-reported being diagnosed or treated for depression and 231,747 healthy controls of similar ethnicity. These data had been shared by people who purchased their own genetic profiles via the 23 and Me website and agreed to participate in the company’s optional research initiative, which makes data available to the scientific community, while protecting privacy.

 

The researchers integrated these data with results from a prior Psychiatric Genomic Consortium genome-wide-association study, based on clinician-vetted diagnoses of more than 20,000 patients and controls of European ancestry. They then followed-up with a closer look at certain statistically suspect sites from that analysis in an independent 23 and Me “replication” sample of 45,773 cases and 106,354 controls.

 

ADVANCE Opinion Poll: What is your overall accuracy rate for ICD-10 coding after the first six months?

 

In all, Perlis and colleagues found 17 genetic variations linked to depression at 15 genome locations. In addition to hinting at a link between depression and brain gene expression during development, there was also evidence of overlap between the genetic basis of depression and other mental illnesses. While the genome sites identified still account for only a fraction of the risk for depression, the researchers say the results support the strategy of complementing more traditional methods with crowd-sourced data.

 

“We hope these findings help people understand that depression is a brain disease, with its own biology,” said Perlis. “Now comes the hard work of using these new insights to try to develop better treatments.”

 

For more information, visit genome.gov and nih.gov.

You Might Also Like...

Patients & Providers Working Together

Population health management calls for the re-engineering of engagement.

Why Are Claims Denied?

Three reasons are at the root of most denials.

Consumer Segmentation Analytics

The evolving medical benefit landscape makes consumer segmentation a must.

Population Health Management

Empowering providers, caregivers and coders.

0 comments

leave a comment



To prevent comment spam, please type the code you see below into the code field before submitting your comment. If you cannot read the numbers in the image, reload the page to generate a new one.

Captcha
Enter the security code below:
 

Search

About this Blog


    ADVANCE Editorial Staff
    Occupation: Editor
    Setting: ADVANCE for Healthcare Information Professionals
  • About Blog and Author

Keep Me Updated